Short Interest in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Decreases By 39.1%

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 520,300 shares, a decline of 39.1% from the January 31st total of 853,700 shares. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.4% of the company’s shares are sold short.

Inspira Technologies Oxy B.H.N. Price Performance

Shares of IINN stock traded up $0.07 on Friday, reaching $0.90. 764,602 shares of the company’s stock were exchanged, compared to its average volume of 1,720,566. Inspira Technologies Oxy B.H.N. has a 52 week low of $0.77 and a 52 week high of $2.45. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.23 and a quick ratio of 2.13. The company’s fifty day simple moving average is $0.98 and its 200 day simple moving average is $1.15.

Institutional Investors Weigh In On Inspira Technologies Oxy B.H.N.

A hedge fund recently raised its stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC increased its holdings in shares of Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) by 142.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 36,622 shares of the company’s stock after acquiring an additional 21,532 shares during the period. Renaissance Technologies LLC owned about 0.29% of Inspira Technologies Oxy B.H.N. worth $37,000 at the end of the most recent quarter. 12.72% of the stock is currently owned by institutional investors.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.